“This change is necessary as part of our expansion into the U.S. capital markets. By changing to ‘Nobilis’ we will avoid potential confusion with companies and funds using the ‘Northstar’ name on exchange in the United States,” said Nobilis President Harry Fleming, according to the report.
Christopher Lloyd of Athas Health assumed the role CEO for the combined companies.
More articles on ASC issues:
7 things for ASC leaders to know for Monday
5 core concepts on ASC relationships with payers
12 ASC management & development company CDOs to know
